Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark I Greene

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Immunologic Research|July 15, 2003
Anergy and suppression as coexistent mechanisms for the maintenance of peripheral T cell tolerancePatrick J Brennan, Sandra J Saouaf, Mark I Greene, et al.
Frontiers in Immunology|April 25, 2020
PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine SignalingYukinori Tanaka, Yasuhiro Nagai, Mariko Okumura, et al.
Immunology and Cell Biology|November 30, 2011
Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activityHongtao Zhang, Yan Xiao, Zhiqiang Zhu, et al.
Immunologic Research|January 10, 2004
Mechanisms of peripheral immune tolerance: conversion of the immune to the unresponsive phenotypeSandra J Saouaf, Patrick J Brennan, Yuan Shen, et al.
Experimental and Molecular Pathology|May 7, 2013
Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancersTaofeng Du, Yasuhiro Nagai, Yan Xiao, et al.
International Immunopharmacology|June 23, 2009
Structural aspects of the FOXP3 regulatory complex as an immunopharmacological targetZhaocai Zhou, Xiaomin Song, Alan Berezov, et al.
Advances in Experimental Medicine and Biology|February 1, 2021
A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEXTengyun Ma, Xiaomin Song, Ciriaco A Piccirillo, et al.
Experimental and Molecular Pathology|October 20, 2007
CD147 immunoglobulin superfamily receptor function and role in pathologyKathryn T Iacono, Amy L Brown, Mark I Greene, et al.
Scientific Reports|November 17, 2015
Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitisSusan Morvaridi, Deepti Dhall, Mark I Greene, et al.
Nature Reviews. Drug Discovery|October 27, 2009
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cellsLiqing Wang, Edwin F de Zoeten, Mark I Greene, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Immunologic Research|July 15, 2003
Anergy and suppression as coexistent mechanisms for the maintenance of peripheral T cell tolerancePatrick J Brennan, Sandra J Saouaf, Mark I Greene, et al.
Frontiers in Immunology|April 25, 2020
PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine SignalingYukinori Tanaka, Yasuhiro Nagai, Mariko Okumura, et al.
Immunology and Cell Biology|November 30, 2011
Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activityHongtao Zhang, Yan Xiao, Zhiqiang Zhu, et al.
Immunologic Research|January 10, 2004
Mechanisms of peripheral immune tolerance: conversion of the immune to the unresponsive phenotypeSandra J Saouaf, Patrick J Brennan, Yuan Shen, et al.
Experimental and Molecular Pathology|May 7, 2013
Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancersTaofeng Du, Yasuhiro Nagai, Yan Xiao, et al.
International Immunopharmacology|June 23, 2009
Structural aspects of the FOXP3 regulatory complex as an immunopharmacological targetZhaocai Zhou, Xiaomin Song, Alan Berezov, et al.
Advances in Experimental Medicine and Biology|February 1, 2021
A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEXTengyun Ma, Xiaomin Song, Ciriaco A Piccirillo, et al.
Experimental and Molecular Pathology|October 20, 2007
CD147 immunoglobulin superfamily receptor function and role in pathologyKathryn T Iacono, Amy L Brown, Mark I Greene, et al.
Scientific Reports|November 17, 2015
Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitisSusan Morvaridi, Deepti Dhall, Mark I Greene, et al.
Nature Reviews. Drug Discovery|October 27, 2009
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cellsLiqing Wang, Edwin F de Zoeten, Mark I Greene, et al.
Pageof 12